• Media Centre
  • Investor relations
  • Client area
  • Client area
  • Stewardship policy
  • Annual reports service

Form of Proxy

ABCELLERA BIOLOGICS INC.

Notes

No. Proposition For Against Abstain
1

Election of class II Director to serve until the 2028 Annual Meeting of Shareholders and until his or her successor has been duly elected and qualified: Carl L. G. Hansen, Ph.D.

2

Election of class II Director to serve until the 2028 Annual Meeting of Shareholders and until his or her successor has been duly elected and qualified: Michael Hayden, MBCHB (M.D.), Ph.D.

3

To ratify the appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025.

4

To approve, on a non-binding advisory basis, the compensation of the Companys named executive officers, or Say-on-Pay.